sysa1801
elevation oncology,cspc pharmaceuticals,spdr s&p biotech,milestone pharma,ishares biotechnology
['cspc', 'sysa-1801', '$cspcy', 'milestone,(-milestones)', 'cspc ', '$ibb', '$xbi', 'elevation oncology']
$cspcy $wst exciting news in oncology! cspc pharmaceutical group to present first-in-human phase 1 clinical data for sysa-1801 at asco 2023, marking a major milestone for elevation oncology's drug development. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt